Your Lab Partner®
Catalog of Stem Cell Lines
Stem Cell Protocols
Stem Cell Technical Support
Overview of Order Process
Stem Cell FAQs
Send Samples for Testing
Request Pricing Information
WiCell Cloud LogIn
SNP Microarray
Spectral Karyotyping (SKY)
Short Tandem Repeat (STR)
Mycoplasma Detection by PCR
Recurrents and Associated Papers
NIH Rigor and Reproducibility
Characterization FAQs
Reagent Testing
Quality Control Testing
WiCellSAFE
Cell Banking
Contract Banking
Depositing Cell Lines
UW-Madison Support
WiCell Posters & Publications
-- Select Page -- Leadership Meet Our Team UW-Madison Support WiCell Posters & Publications Events Careers Contact Us
About WiCell
Headquartered in Madison, Wisconsin, WiCell is a supporting organization of the University of Wisconsin–Madison, a world leader in the area of human pluripotent stem cell research. WiCell is a nonprofit organization established in 1999 to advance the science of stem cells. The global leader in cell banking, characterization testing and distribution of stem cell lines, WiCell builds on these core strengths by also providing clinical grade pluripotent stem cell lines, quality control testing and cell banking services.
The mission of WiCell is to support stem cell research at the University of Wisconsin–Madison and the development of stem cell applications worldwide.
History of WiCell
In 1998, University of Wisconsin researcher Dr. James Thomson succeeded in isolating and culturing human embryonic stem cells for the first time. Recognizing the potential of these unique cells, and aware that regulations surrounding their use in a university setting were unclear, the Wisconsin Alumni Research Foundation established WiCell in 1999 as a safe haven for the advancement of stem cell research in the politically charged environment of the time.
As a nonprofit research institute, WiCell has consistently worked to advance stem cell technology through research, education and technical support for the scientific community. WiCell established the first comprehensive training program for human embryonic stem (hES) cells that provided instruction to more than 800 scientists from around the globe during its tenure. From 2005 through 2010, WiCell hosted the National Stem Cell Bank, which collected, banked, characterized and distributed the 21 hES cell lines approved for federal funding in the U.S. by then President George W. Bush. WiCell received the highest rating possible from the NIH at the completion of the NIH National Stem Cell Bank contract.
As advancements in technology led to the derivation of human induced pluripotent stem (iPS) cells, WiCell expanded its cell line offerings to include both iPS and modified cell lines, forming the WiCell Stem Cell Bank. Today, WiCell's Stem Cell Bank is home to a growing number of cell lines offered across a variety of culture platforms. The collection contains cell lines submitted from researchers around the globe and includes the original National Stem Cell Bank lines as well as many modified cell lines useful as research tools.
WiCell now offers services developed in conjunction with the Stem Cell Bank to both academic and commercial groups. Established in 2005, WiCell's characterization laboratory provides genetic testing including karyotyping by G-band, fluorescence in situ hybridization (FISH), microarray analysis, spectral karyotyping (SKY), short tandem repeat (STR) analysis and mycoplasma testing. Product screening and quality control testing using human pluripotent stem cells also are available through our core laboratory. Additionally, our highly experienced banking and distribution team offers contract cell banking services to outside organizations. All offerings are made available on a fee-for-service basis.
Stay up-to-date with WiCell
Expand your lab with ours®
Copyright © 2018 WiCell. All rights reserved. | Privacy & Terms